Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells

Journal of Cellular Biochemistry

Volumn 113, Issue 6, 2012, Pages 1886-1895

  Subramanian, Arjunan ^a   Gan, Shu Uin ^a   Ngo, Kae Siang ^a   Gauthaman, Kalamegam ^a   Biswas, Arijit ^a   Choolani, Mahesh ^a   Bongso, Ariff ^a   Fong, Chui Yee ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

cancer cells; human Wharton's jelly stem cells; tumor associated fibroblasts

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL TRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; FIBROBLAST; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WHARTON JELLY;

EID: 84859609690     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24057     Document Type: Article

References (35)

1. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L,. 2009. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PloS Med 6: e1000029: 221-231.
2. Ayuzawa R, Doi C, Rachakatla RS, Pyle MM, Maurya DK, Troyer D,. 2009. Naîve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett 280: 31-37.
3. Bissell MJ, Radisky D,. 2001. Putting tumors in context. Nat Rev Cancer 1: 46-54.
4. Blankenstein T,. 2005. The role of tumor stroma in the interaction between tumor and immune system. Curr Opin Immunol 17: 180-186.
5. Cardone A, Tolino A, Xarcone R, Borruto Caracciolo G, Tartaglia E,. 1997. Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. Panminerva Med 39: 174-177.
6. Fan CG, Zhang Q, Zhou J,. 2011. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev Rep 7: 195-207.
7. Fong CY, Richards M, Manasi N, Biswas A, Bongso A,. 2007. Comparative growth behavior and characterization of stem cells from human Wharton's jelly. Reprod BioMed Online 15: 708-718.
8. Fong CY, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande M,. 2010a. Derivation efficiency, cell proliferation, frozen-thaw survival, stem cell properties and differentiation of human Wharton's jelly stem cells. Reprod BioMed Online 21: 391-401.
9. Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK,. 2010b. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev Rep DOI: 10.1007/s12015-010-9166-x.
10. Fong CY, Subramanian A, Gauthaman K, Venugopal J, Biswas A, Ramakrishna S,. 2011. Human umbilical cord Wharton's Jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment. Stem Cell Rev Rep DOI: 10.1007/s12015-011-9289-8.
11. Ganta C, Chiyo D, Ayuzawa R, Rachakatla R, Pyle M, Andrews G,. 2009. Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res 69: 1815-1820.
12. Gauthaman K, Venugopal JR, Fong CY, Biswas A, Ramakrishna S, Bongso A,. 2010. Osteogenic differentiation of human Wharton's jelly stem cells on nanofibrous substrates in vitro. Tissue Eng Part A 17: 71-81.
13. Gauthaman K, Fong CY, Cheyyatraivendran SA, Subramanian A, Biswas A, Choolani M,. 2011. Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis unlike human embryonic stem cells. Reprod BioMed Online DOI: 10.1016/j.rbmo.2011.10.007.
14. Hu Y, Luo Y, Tan Y, Shi J, Sheng L, Fu H,. 2011. Donor bone marrow-derived stem cells contribute to oral squamous cell carcinoma transformation in a recipient after hematopoietic stem cell transplantation. Stem Cells Dev DOI: 10.1089/scd.2011.0308.
15. Illancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U,. 2007. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77: 577-588.
16. Ishii G, Sangai T, Oda T, Aoyagi Y, Hasebe T, Kanomata N,. 2003. Bone marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 309: 232-240.
17. Jodele S, Chantrain CF, Blavier I, Lutzko C, Crooks GM, Shimada H,. 2005. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 65: 3200-3208.
18. Karahuseyinglu S, Cinar O, Kilic E,. 2007. Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 25: 319-331.
19. Kita K, Gauglitz GG, Phan TT, Herndon DN, Jeschke MG,. 2010. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev 19: 491-502.
20. La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M,. 2009. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: Differentiation potential and detection of new markers. Histochem Cell Biol 131: 267-282.
21. LaRue AC, Masuya M, Ebihara Y, Fleming PA, Visconti RP, Minamiguchi H,. 2006. Hematopoietic origins of fibroblasts associated with solid tumors. Exp Hematol 34: 208-218.
22. Liao D, Luo Y, Markowitz D, Xiang R, Reisfeld RA,. 2009. Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS ONE 4: e7965: 1-10.
23. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP,. 2008. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339.
24. Mishra P, Banerjee D, Ben-Baruch A,. 2011. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukocyte Biol 89: 31-39.
25. Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Briaire-de Bruijn I, de Jong D,. 2009. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 219: 294-305.
26. Musina RA, Bekchanova ES, Belyavskii AV, Grinenko TS, Sukhikh GT,. 2007. Umbilical cord blood mesenchymal stem cells. Bull Exp Biol Med 143: 127-131.
27. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R,. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
28. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE,. 2005. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23: 220-229.
29. Spaeth EK, Dembiski JL, Sasser AK, Watson K, Klopp A, Hall B,. 2009. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE 4: e4992: 1-11.
30. Studeny M, Marini FC, Dembinski JI, Zompetta C, Cabreira-Hansen M, Bekele BN,. 2004. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted delivery vehicles for anticancer agents. J Natl Cancer Inst 96: 1593-1603.
31. Taghizadeh RR, Cetrulo KJ, Cetrulo CL,. 2011. Wharton's jelly stem cells: Future clinical applications. Placenta 32: S311-S315.
32. Troyer DL, Weiss ML,. 2008. Concise review: Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26: 591-599.
33. Wang XY, lan Y, He WY, Zhang L, Yao HY, Hou CM,. 2008. Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. Blood 111: 2436-2443.
34. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, Vanderwerff I,. 2008. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26: 2865-2874.
35. Wels J, Kaplan RN, Rafii S, Lyden D,. 2008. Migratory neighbors and distant invaders: Tumor-associated niche cells. Genes Dev 22: 559-574.